Insights

Anti-arrhythmic medication may alter P-wave morphology (PWM) variations in patients with paroxysmal atrial fibrillation (pAF). This study used ECG analysis to detect significant differences, aiding in non-invasive pAF patient characterization.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Signal Processing

Background:

  • Atrial Fibrillation (AF) is a common arrhythmia linked to atrial remodeling, altering P-wave morphology (PWM) on ECGs.
  • In paroxysmal AF (pAF), PWM changes can be transient, making beat-to-beat analysis crucial for detection.
  • Previous research indicates distinct PWM characteristics can differentiate pAF patients from healthy individuals.

Purpose of the Study:

  • To investigate the impact of anti-arrhythmic medication on beat-to-beat PWM alternations in pAF patients.
  • To explore the potential of ECG signal analysis for non-invasive characterization of low-burden pAF.
  • To assess if medication influences the dynamic changes in P-wave morphology during sinus rhythm.

Main Methods:

  • Collected high-frequency ECG signals (1000Hz) from three orthogonal leads for pAF patients and healthy volunteers.
  • Analyzed beat-to-beat P-wave morphology alternations in patients with minimal/mild AF burden, including those on anti-arrhythmic treatment.
  • Employed Kruskal-Wallis test for group comparisons and a 3-class Random Forest classifier for performance evaluation.

Main Results:

  • Statistically significant differences were observed between the studied groups (pAF patients with/without medication vs. healthy controls).
  • The Random Forest classifier achieved high classification performance with an AUC of 85.75%.
  • Preliminary findings suggest medication influences PWM variability in pAF patients.

Conclusions:

  • The study provides evidence that anti-arrhythmic medication affects beat-to-beat PWM variability in pAF.
  • The developed methodology offers a non-invasive approach for characterizing low-burden pAF patients using ECG.
  • Further understanding of medication effects on P-wave dynamics can improve AF management.

Related Concept Videos

Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
154
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
144
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
478
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.1K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
198
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
149